REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
7.82
-0.03 (-0.38%)
Jan 23, 2025, 12:13 PM EST - Market open
REGENXBIO Market Cap
REGENXBIO has a market cap or net worth of $387.44 million as of January 23, 2025. Its market cap has decreased by -49.39% in one year.
Market Cap
387.44M
Enterprise Value
238.34M
1-Year Change
-49.39%
Ranking
Category
Stock Price
$7.82
Market Cap Chart
Since September 17, 2015, REGENXBIO's market cap has decreased from $749.30M to $387.44M, a decrease of -48.29%. That is a compound annual growth rate of -6.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 375.10M | -2.06% |
| Dec 31, 2024 | 383.00M | -51.50% |
| Dec 29, 2023 | 789.70M | -19.57% |
| Dec 30, 2022 | 981.90M | -29.79% |
| Dec 31, 2021 | 1.40B | -17.57% |
| Dec 31, 2020 | 1.70B | 12.32% |
| Dec 31, 2019 | 1.51B | 0.48% |
| Dec 31, 2018 | 1.50B | 45.18% |
| Dec 29, 2017 | 1.04B | 110.87% |
| Dec 30, 2016 | 491.10M | 12.43% |
| Dec 31, 2015 | 436.80M | -41.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.44B |
| UnitedHealth Group | 483.14B |
| Johnson & Johnson | 356.69B |
| Novo Nordisk | 355.58B |
| AbbVie | 305.03B |
| Merck & Co. | 243.45B |
| Thermo Fisher Scientific | 219.20B |
| Intuitive Surgical | 215.18B |